Who Owns VRPX?
VIRPAX PHARMACEUTICALS INC — Institutional Ownership & 13F Holdings
$0.00
+0.00 (+0.00%)
Market Cap
—
Shares Outstanding
—
Institutional Holders
7
Total Inst. Value
$35K
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | $26K | 22,075 |
| 2 | Tower Research Capital LLC (TRC) | $6K | 4,897 |
| 3 | UBS Group AG | $2K | 2,000 |
| 4 | SBI Securities Co., Ltd. | $130 | 108 |
| 5 | OSAIC HOLDINGS, INC. | $10 | 9 |
| 6 | Vermillion Wealth Management, Inc. | $5 | 4 |
| 7 | BANK OF AMERICA CORP /DE/ | $0 | 5 |
Frequently Asked Questions
How many institutional investors hold VRPX?
As of Q1 2025, 7 institutional investors report holding VRPX (VIRPAX PHARMACEUTICALS INC) in their 13F filings.
Which hedge fund owns the most VRPX?
The largest institutional holder of VRPX is MILLENNIUM MANAGEMENT LLC with $26K in shares.
Are institutions buying or selling VRPX?
This quarter, 7 institutions opened new positions in VRPX and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.